METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation
Esteban A. Orellana(Dartmouth College), Richard I. Gregory(Boston Children's Hospital), Eric S. Fischer(Dana-Farber Cancer Institute), Frank J. Slack(Beth Israel Deaconess Medical Center), Mehdi Pirouz(Boston Children's Hospital), Raja Hussain Ali(Boston Children's Hospital), George S. Vassiliou(Wellcome/MRC Cambridge Stem Cell Institute), Erdem Sendinc(Boston Children's Hospital), Alejandro Gutiérrez(Boston Children's Hospital), Gonçalo J. L. Bernardes(Instituto de Medicina Molecular João Lobo Antunes), Demetrios Aspris(Wellcome Sanger Institute), Eliza Yankova(Wellcome/MRC Cambridge Stem Cell Institute), Muxin Gu(Wellcome/MRC Cambridge Stem Cell Institute), Étienne De Braekeleer(Wellcome Sanger Institute), Wen Cai Zhang(Tongji Hospital), Dimitrios A. Garyfallos(University of Cambridge), Allan Bradley(Granta Design (United Kingdom)), Jihoon Lim(Beth Israel Deaconess Medical Center), Konstantinos Tzelepis(Wellcome/MRC Cambridge Stem Cell Institute), Qi Liu(Boston Children's Hospital), Sigitas Mikutis(University of Cambridge)
Cited by 359
Related Papers
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k
The <i>let-7</i> MicroRNA Represses Cell Proliferation Pathways in Human Cells
|Cancer Research|2007|1.2k
Inverse electron demand Diels–Alder reactions in chemical biology
|Chemical Society Reviews|2017|1.1k
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
|Cell Reports|2016|834
Mitochondrial defect in Huntington's disease caudate nucleus
|Annals of Neurology|1996|738